RT Journal Article
SR Electronic
T1 1518 T-cell inducing oncolytic virus (igrelimogene litadenorepvec; TILT-123) shows safety, anti-tumor activity and induction of immune responses in advanced solid tumor patients (full report on TUNIMO)
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A1743
OP A1743
DO 10.1136/jitc-2023-SITC2023.1518
VO 11
IS Suppl 2
A1 Santos, Joao
A1 Peltola, Katriina
A1 Alanko, Tuomo
A1 Pakola, Santeri A
A1 Clubb, James
A1 Jirovec, Elise
A1 Haybout, Lyna
A1 Kudling, Tatiana V
A1 Korpisaari, Riitta
A1 Juteau, Susanna
A1 Jaakkola, Marjut
A1 Sormunen, Jorma
A1 Kononen, Juha
A1 Quixabeira, Dafne CA
A1 Kistler, Claudia
A1 Sorsa, Suvi
A1 Havunen, Riikka
A1 Cervera-Carrascon, Victor
A1 Hemminki, Akseli
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_2/A1743.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.